This series on "Unresolved Issues in Pancreatic Cancer" is edited by Professor Savio George Barreto from Hepatobiliary & Oesophagogastric Unit, Division of Surgery & Perioperative Medicine, Flinders Medical Centre, Bedford Park, Adelaide, South Australia, Australia; College of Medicine & Public Health, Flinders University, South Australia, Australia.
Birth of a solid organ cancer—the cell fusion hypothesis presented with pancreatic cancer as a model: a narrative review
A narrative review: has regionalization truly achieved its intended goal in the surgical management of pancreatic cancer?
Neoadjuvant therapy in resectable pancreatic cancer—is this the way forward?—a narrative review
Do arterial resections improve survival in pancreatic cancer?—a narrative review
Is enhancing recovery after pancreatic cancer surgery even possible?—a narrative review
Artificial intelligence and imaging for risk prediction of pancreatic cancer: a narrative review
Upfront surgery vs. neoadjuvant therapy for resectable pancreatic cancer: a narrative review of available evidence
Minimally invasive surgery for pancreatic cancer—are we there yet?—a narrative review
Immunotherapy in pancreatic cancer—an emerging role: a narrative review
Genetic landscape of pancreatic cancer: a narrative review
“Mitigation strategies for post-operative pancreatic fistula after pancreaticoduodenectomy in high-risk pancreas: an evidence-based algorithmic approach”—a narrative review
Disclosure:
The series “Unresolved Issues in Pancreatic Cancer” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Dr. Savio George Barreto served as the unpaid Guest Editor for the series.